Squarex Pharmaceutical Corporation (SQRX)

Squarex Pharmaceutical was planning to go public, but the IPO was withdrawn on May 19, 2023.

Stock Price: Pending

IPO price not available yet

Squarex Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2021	2020
Debt / Equity Ratio	-0.42	-0.69	-0.61
Debt / EBITDA Ratio	-0.87	-1.82	-0.47
Debt / FCF Ratio	-1.24	-3.07	-1.10
Quick Ratio	0.02	0.10	0.02
Interest Coverage	-8.11	-5.48	-27.45
Return on Equity (ROE)	54.34%	44.65%	134.75%
Return on Assets (ROA)	-	-415.90%	-15105.94%
Return on Capital (ROIC)	80.88%	121.32%	188.82%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).